date,title,source
Oct-18-18,Can UnitedHealth Group and Johnson & Johnson Continue Their Winning Ways?,Motley Fool
Oct-18-18,Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-18-18,Risk-Reward With Gilead Sciences,GuruFocus.com
Oct-18-18,Edited Transcript of GILD earnings conference call or presentation 25-Jul-18 9:00pm GMT,Thomson Reuters StreetEvents
Oct-18-18,"Market Morning: China, Yuan Crushed; Fed Minutes Sparse, HIV Meets Match, Exxon Wants China",Market Exclusive
Oct-18-18,Is Sangamo Therapeutics Inc. a Buy?,Motley Fool
Oct-19-18,Jackpot stocks that could make you a billionaire,CNBC Videos
Oct-19-18,Could a Diagnostic Be Key to Winning This Big Healthcare Market?,Motley Fool
Oct-19-18,Investors Hunt for Biotech Winners as Wider Stock Market Churns,Bloomberg
Oct-22-18,Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?,Zacks
Oct-22-18,POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET,GlobeNewswire
Oct-22-18,Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet,Business Wire
Oct-23-18,Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today,Motley Fool
Oct-23-18,"Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook",Zacks
Oct-23-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers",Zacks
Oct-24-18,3 Top Healthcare Stocks to Buy Right Now,Motley Fool
Oct-24-18,Gilead earnings: Expect a strong quarter despite executive turnover,MarketWatch
Oct-24-18,Healthcare ETFs to Buy Ahead of Q3 Earnings,Zacks
Oct-24-18,Investors Are Underestimating Gilead Sciences Stock,InvestorPlace
Oct-24-18,"Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG",Zacks
Oct-25-18,"Gilead hepatitis C drug sales fall, but profit beats estimates",Reuters
Oct-25-18,"UPDATE 1-Gilead hepatitis C drug sales fall, but profit beats estimates",Reuters
Oct-25-18,Gilead 3rd quarter profit falls as hepatitis C drug sales wane,Reuters
Oct-25-18,Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates,Zacks
Oct-25-18,Gilead's stock gains on better-than-expected earnings,MarketWatch
Oct-25-18,"Gilead Beats Third-Quarter Sales, Adjusted Profit Views",Investor's Business Daily
Oct-25-18,Gilead Sciences Announces Fourth Quarter 2018 Dividend,Business Wire
Oct-25-18,Gilead Sciences Announces Third Quarter 2018 Financial Results,Business Wire
Oct-25-18,"Gilead Sciences beats earnings, revenues expectations",CNBC Videos
Oct-25-18,Gilead earnings: Expect a strong quarter despite executive turnover,MarketWatch
Oct-25-18,A Preview Of Gilead's Q3 Earnings,Benzinga
Oct-26-18,Gilead Sciences Stock Is Back to Base  Go Long,InvestorPlace
Oct-26-18,Gilead Sciences Stock Divides Analysts After Earnings Report,Barrons.com
Oct-26-18,"Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View",Zacks
Oct-26-18,"[$$] Stocks to Watch: Amazon, Alphabet, Intel, Chipotle, Snap, Expedia",The Wall Street Journal
Oct-26-18,The bigger message behind Amgens decision to slash cost of its Repatha cholesterol drug,MarketWatch
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-26-18,"Today's Research Reports on Trending Tickers: Gilead Sciences, Inc. and Esperion Therapeutics, Inc.",ACCESSWIRE
Oct-26-18,"Gilead Sciences' 3rd Quarter: Good News Gets Better, Bad News Gets Worse",Motley Fool
Oct-26-18,Gilead Sciences Inc (GILD) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-26-18,Edited Transcript of GILD earnings conference call or presentation 25-Oct-18 8:30pm GMT,Thomson Reuters StreetEvents
Oct-29-18,Edited Transcript of GILD earnings conference call or presentation 25-Oct-18 8:30pm GMT,Thomson Reuters StreetEvents
Oct-29-18,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know,Zacks
Oct-29-18,"Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the price.",American City Business Journals
Oct-29-18,Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2,Zacks
Oct-29-18,7 Rising Healthcare Stocks to Consider,InvestorPlace
Oct-29-18,The bigger message behind Amgens decision to slash cost of its Repatha cholesterol drug,MarketWatch
Oct-29-18,Be Ready to Ride the Dividend on Gilead Sciences,TheStreet.com
Oct-29-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)",Zacks
Oct-31-18,Jerome Dodson Comments on Gilead Sciences,GuruFocus.com
Oct-31-18,Gilead shares drop after new UnitedHealth program incentivizes cheaper HIV meds,MarketWatch
Oct-31-18,Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies,Business Wire
Oct-31-18,"Investor Expectations to Drive Momentum within Gilead Sciences, SCANA, Brink's, Fortive, Asbury Automotive Group, and Helmerich & Payne  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-31-18,"Market Morning: Record Down Days, Biotech Buyback Busts, Coke Raising Prices, Credit Tightens",Market Exclusive
Nov-01-18,Biotech ETFs in Focus on String of Q3 Earnings Beat,Zacks
Nov-01-18,Gilead to Present Latest Scientific Research in Hematologic Malignancies and Solid Tumors at ASH 2018,Business Wire
Nov-01-18,"3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte",InvestorPlace
Nov-01-18,Today's Research Reports on Trending Tickers: Gilead Sciences and BeiGene,ACCESSWIRE
Nov-01-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals",Zacks
Nov-05-18,Exclusive: Small Peninsula city rejects developer's housing plan  and tells it to go bigger,American City Business Journals
Nov-05-18,"Why Gilead Sciences, Inc. Stock Broke Down in October",Motley Fool
Nov-08-18,Is Gilead Sciences Incs (NASDAQ:GILD) Balance Sheet Strong Enough To Weather A Storm?,Simply Wall St.
Nov-08-18,Biotech stocks have been hit hard  here are ones analysts like best for a rebound,MarketWatch
Nov-08-18,East Bay biotech scores $42 million with potential quick-fix for heart trouble,American City Business Journals
Nov-08-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-12-18,"Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27",Business Wire
Nov-13-18,Express Scripts offers new formulary for lower list-price drugs,Reuters
Nov-14-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-14-18,"Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges",Zacks
Nov-15-18,BeiGene (BGNE) Catches Eye: Stock Jumps 8.3%,Zacks
Nov-19-18,Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta,Zacks
Nov-19-18,Tesaro Stock Sinks in Aftermath of Sale Rumors,InvestorPlace
Nov-19-18,Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension,Zacks
Nov-20-18,Gilead's Vemlidy Gets Approval in China for HBV Infection,Zacks
Nov-20-18,Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint,Zacks
Nov-21-18,"Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal",Zacks
Nov-21-18,Should Value Investors Consider Gilead (GILD) Stock Now?,Zacks
Nov-23-18,Novartis Gets Approval for Gene Therapy Luxturna in Europe,Zacks
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-26-18,"Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth",Zacks
Nov-27-18,Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial,Zacks
Nov-27-18,"Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate",Zacks
Nov-27-18,Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial,Zacks
Nov-27-18,Roche buys U.S. biotech Jecure in race for liver disease drugs,Reuters
Nov-27-18,5 Biotech Stocks to Scoop Up for Big Dividends,InvestorPlace
Nov-27-18,Eyenovia Initiates Phase III Study for Mydriasis Candidate,Zacks
Nov-27-18,Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors,Zacks
Nov-27-18,"Wall Street Wants the Best Patents, Not the Best Drugs",Bloomberg
Nov-28-18,Novartis (NVS) Receives EC Approval for Neulasta Biosimilar,Zacks
Nov-28-18,Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity,Zacks
Nov-28-18,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment,Zacks
Nov-28-18,Aileron Inks Collaboration Deal With Pfizer for Cancer Combo,Zacks
Nov-29-18,Merck (MRK) Receives Approval for 2 HIV Medicines in EU,Zacks
Nov-29-18,Roche (RHHBY) to Acquire Jecure and Enter the NASH Space,Zacks
Nov-29-18,Catalyst's Firdapse Receives FDA Approval for Rare Disease,Zacks
Nov-30-18,3 Top Dividend Stocks With Yields Over 3%,Motley Fool
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Key Pharma Players With HIV Focus Ahead of World Aids Day,Zacks
Nov-30-18,Bayer (BAYRY) to Restructure Business & Reduce Headcount,Zacks
